Concepts (107)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Milk, Human | 7 | 2025 | 7 | 1.740 |
Why?
|
| Infant, Premature | 7 | 2025 | 16 | 1.270 |
Why?
|
| Gestational Age | 3 | 2025 | 8 | 0.960 |
Why?
|
| Mothers | 3 | 2025 | 17 | 0.750 |
Why?
|
| Breast Feeding | 4 | 2025 | 14 | 0.710 |
Why?
|
| Infant, Newborn | 9 | 2025 | 57 | 0.700 |
Why?
|
| Infant, Premature, Diseases | 2 | 2018 | 2 | 0.690 |
Why?
|
| Enterocolitis, Necrotizing | 2 | 2018 | 2 | 0.690 |
Why?
|
| Intensive Care, Neonatal | 1 | 2017 | 1 | 0.550 |
Why?
|
| Intensive Care Units, Neonatal | 4 | 2025 | 5 | 0.520 |
Why?
|
| Humans | 12 | 2025 | 1907 | 0.510 |
Why?
|
| Infant Care | 1 | 2015 | 1 | 0.480 |
Why?
|
| Mother-Child Relations | 1 | 2015 | 3 | 0.480 |
Why?
|
| Informed Consent | 1 | 2015 | 7 | 0.480 |
Why?
|
| Decision Making | 1 | 2015 | 14 | 0.480 |
Why?
|
| Female | 7 | 2025 | 984 | 0.420 |
Why?
|
| Milk Banks | 3 | 2020 | 3 | 0.410 |
Why?
|
| Adult | 3 | 2025 | 554 | 0.350 |
Why?
|
| Male | 7 | 2025 | 1055 | 0.350 |
Why?
|
| Retrospective Studies | 4 | 2025 | 102 | 0.330 |
Why?
|
| Patient Discharge | 1 | 2025 | 11 | 0.230 |
Why?
|
| Pregnancy | 1 | 2025 | 44 | 0.230 |
Why?
|
| Cross-Sectional Studies | 1 | 2025 | 64 | 0.220 |
Why?
|
| United States | 1 | 2025 | 157 | 0.220 |
Why?
|
| Tissue Donors | 2 | 2020 | 7 | 0.190 |
Why?
|
| Respiration | 1 | 2001 | 2 | 0.180 |
Why?
|
| Bedding and Linens | 1 | 2001 | 2 | 0.180 |
Why?
|
| Carbon Dioxide | 1 | 2001 | 4 | 0.180 |
Why?
|
| Oxygen | 1 | 2001 | 8 | 0.180 |
Why?
|
| Sleep | 1 | 2001 | 36 | 0.180 |
Why?
|
| Intestinal Atresia | 1 | 2020 | 1 | 0.160 |
Why?
|
| Gastroschisis | 1 | 2020 | 1 | 0.160 |
Why?
|
| Intestine, Small | 1 | 2020 | 4 | 0.160 |
Why?
|
| Cell Death | 1 | 2018 | 3 | 0.140 |
Why?
|
| Intestinal Mucosa | 1 | 2018 | 9 | 0.140 |
Why?
|
| Inflammation | 1 | 2018 | 20 | 0.140 |
Why?
|
| Nod1 Signaling Adaptor Protein | 1 | 2017 | 1 | 0.140 |
Why?
|
| Gram-Positive Bacterial Infections | 1 | 2017 | 2 | 0.140 |
Why?
|
| Infant, Extremely Low Birth Weight | 1 | 2017 | 3 | 0.140 |
Why?
|
| Bacteremia | 1 | 2017 | 4 | 0.140 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2017 | 20 | 0.130 |
Why?
|
| Infant | 3 | 2025 | 89 | 0.130 |
Why?
|
| Breast Milk Expression | 1 | 2015 | 1 | 0.120 |
Why?
|
| Interviews as Topic | 1 | 2015 | 8 | 0.120 |
Why?
|
| Qualitative Research | 1 | 2015 | 15 | 0.120 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2015 | 10 | 0.120 |
Why?
|
| Deamino Arginine Vasopressin | 1 | 2013 | 1 | 0.100 |
Why?
|
| Enterovirus Infections | 1 | 2013 | 1 | 0.100 |
Why?
|
| Meningoencephalitis | 1 | 2013 | 1 | 0.100 |
Why?
|
| Diabetes Insipidus, Neurogenic | 1 | 2013 | 1 | 0.100 |
Why?
|
| Pharmacopoeias as Topic | 1 | 2012 | 1 | 0.100 |
Why?
|
| Cardiovascular Agents | 1 | 2012 | 2 | 0.100 |
Why?
|
| Heart Diseases | 1 | 2012 | 3 | 0.100 |
Why?
|
| Pediatrics | 1 | 2012 | 4 | 0.100 |
Why?
|
| Ventricular Pressure | 1 | 1996 | 1 | 0.060 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 1996 | 6 | 0.060 |
Why?
|
| Lidocaine | 1 | 1996 | 9 | 0.060 |
Why?
|
| Ion Channel Gating | 1 | 1996 | 52 | 0.060 |
Why?
|
| Infant Nutritional Physiological Phenomena | 1 | 2025 | 1 | 0.060 |
Why?
|
| Pulmonary Gas Exchange | 1 | 2001 | 1 | 0.050 |
Why?
|
| Methods | 1 | 2001 | 3 | 0.050 |
Why?
|
| Air | 1 | 2001 | 2 | 0.050 |
Why?
|
| Environment | 1 | 2001 | 2 | 0.050 |
Why?
|
| Tidal Volume | 1 | 2001 | 3 | 0.050 |
Why?
|
| Sudden Infant Death | 1 | 2001 | 17 | 0.050 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2001 | 1 | 0.040 |
Why?
|
| Organ Transplantation | 1 | 2001 | 2 | 0.040 |
Why?
|
| Immunosuppressive Agents | 1 | 2001 | 4 | 0.040 |
Why?
|
| Antiviral Agents | 1 | 2001 | 8 | 0.040 |
Why?
|
| Postoperative Complications | 1 | 2001 | 23 | 0.040 |
Why?
|
| Enteral Nutrition | 1 | 2020 | 2 | 0.040 |
Why?
|
| Hospitalization | 1 | 2020 | 22 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2020 | 119 | 0.040 |
Why?
|
| Child, Preschool | 2 | 2013 | 87 | 0.040 |
Why?
|
| Caco-2 Cells | 1 | 2018 | 1 | 0.040 |
Why?
|
| Oxidative Stress | 1 | 2018 | 4 | 0.040 |
Why?
|
| Lipopolysaccharides | 1 | 2018 | 8 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2018 | 21 | 0.040 |
Why?
|
| Biomarkers | 1 | 2018 | 56 | 0.030 |
Why?
|
| Gene Frequency | 1 | 2017 | 9 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2017 | 9 | 0.030 |
Why?
|
| Birth Weight | 1 | 2017 | 3 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2017 | 14 | 0.030 |
Why?
|
| Logistic Models | 1 | 2017 | 27 | 0.030 |
Why?
|
| Child | 2 | 2012 | 157 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2017 | 41 | 0.030 |
Why?
|
| Phenotype | 1 | 2017 | 52 | 0.030 |
Why?
|
| Risk Factors | 1 | 2017 | 143 | 0.030 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2016 | 2 | 0.030 |
Why?
|
| Child Development | 1 | 2016 | 7 | 0.030 |
Why?
|
| Biomedical Research | 1 | 2016 | 9 | 0.030 |
Why?
|
| Ampicillin | 1 | 2013 | 1 | 0.030 |
Why?
|
| Enterovirus B, Human | 1 | 2013 | 1 | 0.030 |
Why?
|
| Gentamicins | 1 | 2013 | 3 | 0.030 |
Why?
|
| Cardiology | 1 | 2012 | 3 | 0.020 |
Why?
|
| Disease Management | 1 | 2012 | 10 | 0.020 |
Why?
|
| Isotonic Solutions | 1 | 1996 | 1 | 0.020 |
Why?
|
| Verapamil | 1 | 1996 | 3 | 0.020 |
Why?
|
| Chick Embryo | 1 | 1996 | 9 | 0.020 |
Why?
|
| Sodium Channels | 1 | 1996 | 7 | 0.020 |
Why?
|
| Calcium Channel Blockers | 1 | 1996 | 13 | 0.020 |
Why?
|
| Models, Biological | 1 | 1996 | 99 | 0.010 |
Why?
|
| Animals | 1 | 1996 | 748 | 0.010 |
Why?
|
| Lymphoma | 1 | 2001 | 1 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2001 | 14 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2001 | 8 | 0.010 |
Why?
|
| Adolescent | 1 | 2001 | 188 | 0.010 |
Why?
|